Parkinson’s Disease and the COVID-19 Pandemic

The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients

(2020) Yan‐Chao Li et al.   JOURNAL OF MEDICAL VIROLOGY

Steroid‐responsive encephalitis in Covid‐19 disease

(2020) Andrea Pilotto et al.   ANNALS OF NEUROLOGY

Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment

(2020) Sandra P. Smieszek et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19

(2020) Serge Nataf   JOURNAL OF MEDICAL VIROLOGY

Onset of Covid-19 with impaired consciousness and ataxia: a case report

(2020) R. Balestrino et al.   JOURNAL OF NEUROLOGY

Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 Era

(2020) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Mental health, physical activity and quality of life in Parkinson's disease during COVID‐19 pandemic

(2020) Ali Shalash et al.   MOVEMENT DISORDERS

Impact of the COVID ‐19 Pandemic on Parkinson's Disease and Movement Disorders

(2020) Stella M. Papa et al.   MOVEMENT DISORDERS

SARS‐CoV ‐2: At the Crossroad Between Aging and Neurodegeneration

(2020) Alice Lippi et al.   MOVEMENT DISORDERS

A Post‐COVID ‐19 Parkinsonism in the Future?

(2020) Aliaksandr V. Boika   MOVEMENT DISORDERS

Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease ( COVID ‐19) Pandemic

(2020) Mehri Salari et al.   MOVEMENT DISORDERS

Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study

(2020) Roberto Cilia et al.   MOVEMENT DISORDERS

Outcome of Parkinson's Disease Patients Affected by COVID ‐19

(2020) Angelo Antonini et al.   MOVEMENT DISORDERS

Parkinson's Disease and COVID ‐19: Perceptions and Implications in Patients and Caregivers

(2020) Shweta Prasad et al.   MOVEMENT DISORDERS

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

(2020) David E. Gordon et al.   NATURE

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy

(2020) Tommaso Schirinzi et al.   NEUROLOGICAL SCIENCES

Generalized myoclonus in COVID-19

(2020) Pablo Rábano-Suárez et al.   NEUROLOGY

Rapid worsening in Parkinson's disease may hide COVID-19 infection

(2020) Elodie Hainque et al.   PARKINSONISM & RELATED DISORDERS

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

(2020) Jaber S. Alqahtani et al.   PLoS One

The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities

(2020) Rick C. Helmich et al.   Journal of Parkinsons Disease

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

(2020) Ling Mao et al.   JAMA Neurology

Vitamin-D and COVID-19: do deficient risk a poorer outcome?

(2020) Fiona Mitchell   Lancet Diabetes & Endocrinology

Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson’s Disease in Germany

(2020) Hannah M. Zipprich et al.   Journal of Clinical Medicine

Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease

(2020) Casey A. Hribar et al.   Brain Sciences

SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis

(2020) Chitra Mohinder Singh Singal et al.   ACS Chemical Neuroscience

Amantadine Treatment for People with COVID-19

(2020) Ramiro Araújo et al.   ARCHIVES OF MEDICAL RESEARCH

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

(2020) Ross W Paterson et al.   BRAIN

Neuropathologic features of four autopsied COVID‐19 patients

(2020) Jonas Kantonen et al.   BRAIN PATHOLOGY

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

(2020) Liuliu Yang et al.   Cell Stem Cell

A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review

(2020) Nima Fadakar et al.   CEREBELLUM

Patterns of smell recovery in 751 patients affected by the COVID‐19 outbreak

(2020) C. M. Chiesa‐Estomba et al.   EUROPEAN JOURNAL OF NEUROLOGY

Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement

(2020) Scott R. Beach et al.   GENERAL HOSPITAL PSYCHIATRY

Use of amantadine in a patient with SARS‐CoV‐2

(2020) Gonzalo Emiliano Aranda‐Abreu et al.   JOURNAL OF MEDICAL VIROLOGY

Postinfectious brainstem encephalitis associated with SARS-CoV-2

(2020) Anthony Khoo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies

(2020) Stephan Grimaldi et al.   JOURNAL OF NUCLEAR MEDICINE

Neurological associations of COVID-19

(2020) Mark A Ellul et al.   LANCET NEUROLOGY

Amantadine as a drug to mitigate the effects of COVID-19

(2020) Gonzalo Emiliano Aranda Abreu et al.   MEDICAL HYPOTHESES

Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic

(2020) Christopher Kobylecki et al.   MOVEMENT DISORDERS

Impact of COVID ‐19 pandemic on cognition in Parkinson's disease

(2020) Giovanni Palermo et al.   MOVEMENT DISORDERS

The Possible Protective Role of α‐Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease

(2020) Sofiane Ait Wahmane et al.   MOVEMENT DISORDERS

COVID ‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy

(2020) Alfonso Fasano et al.   MOVEMENT DISORDERS

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

(2020) Laura Riva et al.   NATURE

New insights into the neurological effects of COVID-19

(2020) Heather Wood   Nature Reviews Neurology

Temblor y ataxia en COVID-19

(2020) A.M. Diezma-Martín et al.   NEUROLOGIA

Does amantadine have a protective effect against COVID-19?

(2020) Albert Cortés Borra   Neurologia i Neurochirurgia Polska

Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection

(2020) Antonio Méndez-Guerrero et al.   NEUROLOGY

New onset neurologic events in people with COVID-19 infection in three regions in China

(2020) Weixi Xiong et al.   NEUROLOGY

Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review

(2020) João Vitor Vieira de Siqueira et al.   Obesity Research & Clinical Practice

Predictors of COVID-19 outcome in Parkinson's disease

(2020) Alfonso Fasano et al.   PARKINSONISM & RELATED DISORDERS

Acute meningoencephalitis in a patient with COVID-19

(2020) H. Chaumont et al.   REVUE NEUROLOGIQUE

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

(2020) Konrad Rejdak et al.   Multiple Sclerosis and Related Disorders

Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients

(2020) David García-Azorín et al.   Frontiers in Neurology

Targeting COVID-19 in Parkinson’s patients: Drugs repurposed.

(2020) Firoz Anwar et al.   CURRENT MEDICINAL CHEMISTRY

Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study

(2020) Andrea Pilotto et al.   JOURNAL OF INFECTIOUS DISEASES

COVID-19 in Parkinson’s disease: what holds the key?

(2020) R. Sainz-Amo et al.   JOURNAL OF NEUROLOGY

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

(2020) Eleonora Del Prete et al.   JOURNAL OF NEUROLOGY

Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV

(2020) Jinyu Xu et al.   JOURNAL OF NEUROLOGY

COVID-19 impact on consecutive neurological patients admitted to the emergency department

(2020) Andrea Pilotto et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A case of probable Parkinson's disease after SARS-CoV-2 infection

(2020) Mikhal E Cohen et al.   LANCET NEUROLOGY

Telemedicine in Movement Disorders: Leçons du Coronavirus Disease 2019

(2020) Eoin Mulroy et al.   MOVEMENT DISORDERS

Coronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case

(2020) Ingrid Faber et al.   MOVEMENT DISORDERS

A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City

(2020) Jennifer A. Frontera et al.   NEUROLOGY

Is COVID-19 a Perfect Storm for Parkinson’s Disease?

(2020) Patrik Brundin et al.   TRENDS IN NEUROSCIENCES

Parkinson's Disease Remote Patient Monitoring During the COVID-19 Lockdown

(2020) Francesco Motolese et al.   Frontiers in Neurology

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

(2020) David Sulzer et al.   npj Parkinsons Disease

A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

(2019) Alberto J. Espay et al.   MOVEMENT DISORDERS

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial

(2019) Nicolien M van der Kolk et al.   LANCET NEUROLOGY

Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

(2019) Ana I. Rodriguez-Perez et al.   BRAIN BEHAVIOR AND IMMUNITY

Influence of Parkinsonism on outcomes of elderly pneumonia patients

(2018) Taisuke Jo et al.   PARKINSONISM & RELATED DISORDERS

Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection

(2017) Viviane Labrie et al.   Journal of Innate Immunity

The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease

(2017) Ruth B Schneider et al.   LANCET NEUROLOGY

Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson’s disease

(2017) Natalie Kintz et al.   NEUROREPORT

Alpha-Synuclein, a Novel Viral Restriction Factor Hiding in Plain Sight

(2016) Aaron R. Massey et al.   DNA AND CELL BIOLOGY

Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI

(2016) Nathaniel B. Bone et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

(2016) Lauren Hirsch et al.   NEUROEPIDEMIOLOGY

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease

(2016) Xiao-Yan Qin et al.   JAMA Neurology

Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain

(2015) Erica L. Beatman et al.   JOURNAL OF VIROLOGY

A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders

(2014) Amir Abdolahi et al.   Health Informatics Journal

Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease

(2014) Wenbin Xiao et al.   IMMUNOBIOLOGY

Delirium and High Fever Are Associated with Subacute Motor Deterioration in Parkinson Disease: A Nested Case-Control Study

(2014) Atsushi Umemura et al.   PLoS One

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease

(2013) Giselle M Petzinger et al.   LANCET NEUROLOGY

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

(2013) H. Ding et al.   NEUROLOGY

Clinical Characteristics of Exacerbations in Parkinson Disease

(2012) Karen S. Zheng et al.   NEUROLOGIST

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

(2010) J. J. Gagne et al.   NEUROLOGY

The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

(2009) Belen Joglar et al.   JOURNAL OF NEUROCHEMISTRY